These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 20846406)
1. High-risk HPV E5-induced cell fusion: a critical initiating event in the early stage of HPV-associated cervical cancer. Gao P; Zheng J Virol J; 2010 Sep; 7():238. PubMed ID: 20846406 [TBL] [Abstract][Full Text] [Related]
2. The Autophagy Process in Cervical Carcinogenesis: Role of Non-Coding-RNAs, Molecular Mechanisms, and Therapeutic Targets. Lagunas-Martínez A; Madrid-Marina V; Gómez-Cerón C; Deas J; Peralta-Zaragoza O Cells; 2022 Apr; 11(8):. PubMed ID: 35456001 [TBL] [Abstract][Full Text] [Related]
3. Hallmarks of HPV carcinogenesis: The role of E6, E7 and E5 oncoproteins in cellular malignancy. Estêvão D; Costa NR; Gil da Costa RM; Medeiros R Biochim Biophys Acta Gene Regul Mech; 2019 Feb; 1862(2):153-162. PubMed ID: 30707946 [TBL] [Abstract][Full Text] [Related]
4. Modulation of apoptosis by early human papillomavirus proteins in cervical cancer. Lagunas-Martínez A; Madrid-Marina V; Gariglio P Biochim Biophys Acta; 2010 Jan; 1805(1):6-16. PubMed ID: 19374936 [TBL] [Abstract][Full Text] [Related]
6. Tanshinone IIA inhibits viral oncogene expression leading to apoptosis and inhibition of cervical cancer. Munagala R; Aqil F; Jeyabalan J; Gupta RC Cancer Lett; 2015 Jan; 356(2 Pt B):536-46. PubMed ID: 25304375 [TBL] [Abstract][Full Text] [Related]
7. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells. Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252 [TBL] [Abstract][Full Text] [Related]
9. Piwil2 is reactivated by HPV oncoproteins and initiates cell reprogramming via epigenetic regulation during cervical cancer tumorigenesis. Feng D; Yan K; Zhou Y; Liang H; Liang J; Zhao W; Dong Z; Ling B Oncotarget; 2016 Oct; 7(40):64575-64588. PubMed ID: 27602489 [TBL] [Abstract][Full Text] [Related]
10. Potential drugs against cervical cancer: zinc-ejecting inhibitors of the human papillomavirus type 16 E6 oncoprotein. Beerheide W; Bernard HU; Tan YJ; Ganesan A; Rice WG; Ting AE J Natl Cancer Inst; 1999 Jul; 91(14):1211-20. PubMed ID: 10413422 [TBL] [Abstract][Full Text] [Related]
11. The role of human papillomaviruses in oncogenesis. Mighty KK; Laimins LA Recent Results Cancer Res; 2014; 193():135-48. PubMed ID: 24008297 [TBL] [Abstract][Full Text] [Related]
12. Effects of HPV-16 E5, E6 and E7 proteins on survival, adhesion, migration and invasion of trophoblastic cells. Boulenouar S; Weyn C; Van Noppen M; Moussa Ali M; Favre M; Delvenne PO; Bex F; Noël A; Englert Y; Fontaine V Carcinogenesis; 2010 Mar; 31(3):473-80. PubMed ID: 19917629 [TBL] [Abstract][Full Text] [Related]
13. Advances in molecular mechanism of HPV16 E5 oncoprotein carcinogenesis. Chen B; Zhao L; Yang R; Xu T Arch Biochem Biophys; 2023 Sep; 745():109716. PubMed ID: 37553047 [TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus 16/18 E5 promotes cervical cancer cell proliferation, migration and invasion in vitro and accelerates tumor growth in vivo. Liao S; Deng D; Zhang W; Hu X; Wang W; Wang H; Lu Y; Wang S; Meng L; Ma D Oncol Rep; 2013 Jan; 29(1):95-102. PubMed ID: 23128977 [TBL] [Abstract][Full Text] [Related]
15. Understanding the HPV integration and its progression to cervical cancer. Oyervides-Muñoz MA; Pérez-Maya AA; Rodríguez-Gutiérrez HF; Gómez-Macias GS; Fajardo-Ramírez OR; Treviño V; Barrera-Saldaña HA; Garza-Rodríguez ML Infect Genet Evol; 2018 Jul; 61():134-144. PubMed ID: 29518579 [TBL] [Abstract][Full Text] [Related]
16. In vivo HPV 16 E5 mRNA: expression pattern in patients with squamous intra-epithelial lesions of the cervix. Lorenzon L; Mazzetta F; Venuti A; Frega A; Torrisi MR; French D J Clin Virol; 2011 Oct; 52(2):79-83. PubMed ID: 21767984 [TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus type 16 E5 protein as a therapeutic target. Kim SW; Yang JS Yonsei Med J; 2006 Feb; 47(1):1-14. PubMed ID: 16502480 [TBL] [Abstract][Full Text] [Related]
18. Cellular Functions of HPV16 E5 Oncoprotein during Oncogenic Transformation. Gutierrez-Xicotencatl L; Pedroza-Saavedra A; Chihu-Amparan L; Salazar-Piña A; Maldonado-Gama M; Esquivel-Guadarrama F Mol Cancer Res; 2021 Feb; 19(2):167-179. PubMed ID: 33106372 [TBL] [Abstract][Full Text] [Related]
19. Molecular markers predicting the progression and prognosis of human papillomavirus-induced cervical lesions to cervical cancer. Amin FAS; Un Naher Z; Ali PSS J Cancer Res Clin Oncol; 2023 Aug; 149(10):8077-8086. PubMed ID: 37000261 [TBL] [Abstract][Full Text] [Related]
20. Relationship between HPV 16, 18, 31, 33, 45 DNA detection and quantitation and E6/E7 mRNA detection among a series of cervical specimens with various degrees of histological lesions. Baron C; Henry M; Tamalet C; Villeret J; Richet H; Carcopino X J Med Virol; 2015 Aug; 87(8):1389-96. PubMed ID: 25908062 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]